Literature DB >> 27427527

Induction Therapy for Thymoma.

Usman Ahmad1, James Huang2.   

Abstract

Thymomas are uncommon tumors that can present as locally advanced tumors in approximately 30% of the patients. Stage and complete resection are the strongest prognostic factors. For locally advanced tumors, induction treatment may improve the ability to achieve a complete resection. Combination treatment with cisplatin, doxorubicin, and cyclophosphamide is the most commonly used induction regimen. Similar rates of resectability are noted with the use of induction chemotherapy and chemoradiation therapy; however, more tumor necrosis is noted with the addition of radiation.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Chemoradiation; Chemotherapy; Induction treatment; Neoadjuvant; Thymic tumors

Mesh:

Substances:

Year:  2016        PMID: 27427527     DOI: 10.1016/j.thorsurg.2016.04.011

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  6 in total

1.  The change of therapeutic trends in the thymic epithelial tumor.

Authors:  Chang Hyun Kang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate.

Authors:  Jee Won Suh; Seong Yong Park; Chang Young Lee; Seung Hwan Song; Dae Joon Kim; Hyo Chae Paik; Kyoung Young Chung; Min Hee Hong; Hye Ryun Kim; Byoung Chul Cho; Jin Gu Lee
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

3.  Management and Long-Term Outcomes of Advanced Stage Thymoma in the United States.

Authors:  Rhami Khorfan; Ankit Bharat; David D Odell
Journal:  Ann Thorac Surg       Date:  2020-07-11       Impact factor: 4.330

4.  Thymoma size significantly affects the survival, metastasis and effectiveness of adjuvant therapies: a population based study.

Authors:  Dongliang Bian; Feng Zhou; Weiguang Yang; Kaixuan Zhang; Linsong Chen; Gening Jiang; Peng Zhang; Chunyan Wu; Ke Fei; Lei Zhang
Journal:  Oncotarget       Date:  2018-01-23

5.  Does size matter? A national analysis of the utility of induction therapy for large thymomas.

Authors:  Douglas Z Liou; Divya Ramakrishnan; Natalie S Lui; Joseph B Shrager; Leah M Backhus; Mark F Berry
Journal:  J Thorac Dis       Date:  2020-04       Impact factor: 2.895

Review 6.  The role of induction therapy for thymic malignancies: a narrative review.

Authors:  Deven C Patel; Joseph B Shrager; Sukhmani K Padda
Journal:  Mediastinum       Date:  2020-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.